NCT00212277View on ClinicalTrials.gov

Efficacy and Safety,Long-term Study of Low-dose Oral Contraceptive Pill to Treat Dysmenorrhea.

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

February 28, 2005

Primary Completion Date

September 30, 2006

Study Completion Date

February 28, 2007

Conditions
Dysmenorrhea
Interventions
DRUG

Norethindrone,Ethinyl Estradiol

Sponsors

Lead Sponsor

Nobelpharma
All Listed Sponsors
lead

Nobelpharma

INDUSTRY

NCT00212277 - Efficacy and Safety,Long-term Study of Low-dose Oral Contraceptive Pill to Treat Dysmenorrhea. | Biotech Hunter | Biotech Hunter